Aristotle University Of Thessaloniki (AUTH)
Η διερεύνηση των παραγόντων αύξησης και αγγειογένεσης σε ασθενείς με καρκίνο του προστάτη με ή χωρίς οστικές μεταστάσεις: συσχέτιση με καρκινικούς δείκτες και απεικονιστικά ευρήματα
Abstract
dc:descriptionProstate cancer (PCa) is the most common malignancy in males in the United States and Western Europe. PSA and bone scans are important modalities for evaluating and following disease progression. Recently, it was confirmed that angiogenesis plays an important role in the development and spread of a variety of human cancers, including PCa. The aim of this study was to evaluate serum levels of PSA, NSE, of angiogening factors (HER-2, ANG, VEGF-C, MMP2, MMP9, TIMP2, IGF1, IGFBP3) and bone metabolism markers (OPG, PINP, ICTP, CTx) in relation with PCa bone metastatic spread and to assess their expression during disease progression. A total of 204 males were included in the study: 131 patients with prostatic adenocarcinoma, 32 with benign prostatic hyperplasia and 45 healthy male controls. PCa patients were divided into two groups: with and without bone metastases (Κ2 and Κ1 group respectively).Our results support that bone markers PINP, ICTP, CTx and OPG are remarkably elevated in K2 group. Especially OPG shows a high sensitivity and specificity in detecting bone metastatic disease. So, serum bone marker measurement appears to be a promising method for monitoring the efficacy of bone-targeted therapy. In PCa elevated serum NSE values are related with poor prognosis. In our study, NSE levels were significantly higher in advanced metastatic PCa identifing a more aggressive disease, while they did not significantly differ among the other groups. Serum IGF1 and IGFBP-3 levels have been associated with increased risk and advanced stage of PCa. Our results do not support the case for IGF1 and IGFBP3 as potential biomarkers of prostate cancer behavior.ANG expression in prostatic tissue increases as prostatic epithelial cells evolve from a benign to an invasive type. Our results demonstrate that higher serum ANG levels were observed in metastatic patients and in disease progression, indicating that ANG could be a potential marker for monitoring PCa patients in clinical setting.HER-2/neu is an important mediator of cell growth, differentiation and survival. In this study, HER-2 was found to be overexpressed in serum of advanced metastatic prostate cancers revealing that the androgen receptor pathway functions despite anti-androgen therapy in androgen-independent tumors.Matrix metalloproteinases are devoted to the degradation of extracellular matrix. MMP-2 and MMP-9 have been linked to cell invasion and the process of bone metastasis, while TIMP-2 is their tissue inhibitor. Our results show that serum MMP-2, MMP-9 concentrations were higher in metastatic patients, while TIMP-2 was reduced in PCa patients but without significance.Expression of VEGF has been revealed in prostate cells of normal, benign, and malignant phenotypes. In our study, metastatic PCa patients had higher serum VEGF-C levels but without significant difference between controls and organ-confined PCa patients, implying that VEGF-C could not play a crucial role in PCa. Our results are promising and suggest that the above factors, if selected properly and in combination with PSA, could play a role in monitoring therapy and evaluating malignant progression in PCa. Additional studies are needed to investigate their prognostic value in PCa disease-free survival.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Siampanopoulou, Maria
- Σιαμπανοπούλου, Μαρία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36948